About the Company
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the worlds largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $AMGN News
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know
Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
Amgen (AMGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this ...
Relative Strength Alert For Amgen
A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of Amgen Inc (Symbol: AMGN) entered into oversold territory, hitting an RSI reading of 29.6 ...
Amgen declares $2.25 dividend
See AMGN Dividend Scorecard, Yield Chart, & Dividend Growth. Amgen Inc. (AMGN) Presents at TD Cowen 44th Annual Health Care Conference (Transcript) Amgen: A Good Dividend Growth Stock For The ...
AMGEN Inc.
Picking the best bond ETF can be hard with so many options available. Here's what the experts suggest focusing on. Marijuana ETFs have had it rough lately, but risk-tolerant investors can tap ...
AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024
Amgen is committed to unlocking the potential of biology for ... (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, ...
Amgen Inc. (AMGN) Presents at TD Cowen 44th Annual Health Care Conference (Transcript)
I'm Yaron Werber from the Biotech team, and it's a great pleasure to moderate the fireside chat next with Amgen, first fireside chat for the day, so have very high expectations. With us today is ...
Looking At Amgen's Recent Unusual Options Activity
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $230.0 to $285.0 for Amgen over the recent three months. Looking at the volume ...
AMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDEND
Amgen is committed to unlocking the potential of biology for ... (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, ...
FDA Approves Sandoz Biosimilars for Two Blockbuster Amgen Bone Drugs
Sandoz drugs Jubbonti and Xgeva are approved for use in all indications covered by the Amgen products, Prolia and Xgeva. But ...
Loading the latest forecasts...